Genscript Biotech (Germany) Analysis
| G51 Stock | EUR 1.81 0.01 0.56% |
Genscript Biotech is overvalued with Real Value of 1.39 and Hype Value of 1.81. The main objective of Genscript Biotech stock analysis is to determine its intrinsic value, which is an estimate of what Genscript Biotech is worth, separate from its market price. There are two main types of Genscript Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Genscript Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Genscript Biotech's stock to identify patterns and trends that may indicate its future price movements.
The Genscript Biotech stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Genscript Biotech's ongoing operational relationships across important fundamental and technical indicators.
Genscript |
Genscript Stock Analysis Notes
About 38.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 171.82. Genscript Biotech recorded a loss per share of 0.16. The entity last dividend was issued on the 6th of June 2017. Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life sciences research products and services. Genscript Biotech Corporation is a subsidiary of GenScript Corporation. Genscript Biotech operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2620 people. To learn more about Genscript Biotech call Brian Min at 86 25 5889 7288 or check out https://www.genscript.com.Genscript Biotech Investment Alerts
| Genscript Biotech may become a speculative penny stock | |
| Genscript Biotech appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 510.6 M. Net Loss for the year was (347.87 M) with profit before overhead, payroll, taxes, and interest of 303.48 M. | |
| Genscript Biotech has accumulated about 564.61 M in cash with (136.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| Roughly 38.0% of the company shares are held by company insiders |
Genscript Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.85 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genscript Biotech's market, we take the total number of its shares issued and multiply it by Genscript Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Genscript Profitablity
Genscript Biotech's profitability indicators refer to fundamental financial ratios that showcase Genscript Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, Genscript Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Genscript Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Genscript Biotech's profitability requires more research than a typical breakdown of Genscript Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.66) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.64. Technical Drivers
As of the 22nd of July, Genscript Biotech retains the Risk Adjusted Performance of 0.1847, downside deviation of 2.72, and Market Risk Adjusted Performance of 3.89. Genscript Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genscript Biotech standard deviation, information ratio, treynor ratio, as well as the relationship between the variance and jensen alpha to decide if Genscript Biotech is priced fairly, providing market reflects its last-minute price of 1.81 per share.Genscript Biotech Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Genscript Biotech for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Genscript Biotech short-term fluctuations and highlight longer-term trends or cycles.
Genscript Biotech Outstanding Bonds
Genscript Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genscript Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genscript bonds can be classified according to their maturity, which is the date when Genscript Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Genscript Biotech Predictive Daily Indicators
Genscript Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genscript Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.81 | |||
| Day Typical Price | 1.81 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
Genscript Biotech Forecast Models
Genscript Biotech's time-series forecasting models are one of many Genscript Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genscript Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Genscript Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Genscript Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genscript shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Genscript Biotech. By using and applying Genscript Stock analysis, traders can create a robust methodology for identifying Genscript entry and exit points for their positions.
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life sciences research products and services. Genscript Biotech Corporation is a subsidiary of GenScript Corporation. Genscript Biotech operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2620 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Genscript Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Complementary Tools for Genscript Stock analysis
When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |